MLEC
Moolec Science SA Ordinary Shares
NASDAQ: MLEC · HEALTHCARE · BIOTECHNOLOGY
$11.25
+25.14% today
Updated 2026-04-30
Market cap
$5.87M
P/E ratio
—
P/S ratio
0.01x
EPS (TTM)
$-258.69
Dividend yield
—
52W range
$3 – $157
Volume
0.4M
Moolec Science SA Ordinary Shares (MLEC) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating cash flow | $-8802.00 | $-915082.00 | $-7.51M | $-9.33M | $-24.45M |
| Capital expenditures | $0.00 | $0.00 | $179186.00 | $158283.00 | $5.65M |
| Depreciation | $1699.00 | $1699.00 | $122022.00 | $1.01M | $22.25M |
| Stock-based comp | — | $838576.00 | $43.80M | $2.05M | $4.39M |
| Free cash flow | $-8802.00 | $-915082.00 | $-7.69M | $-9.49M | $-30.10M |
| Investing cash flow | — | $-138.00M | $-2.34M | $134865.00 | $-35.99M |
| Financing cash flow | $14491.00 | $139.05M | $11.28M | $11.71M | $13.07M |
| Dividends paid | — | $0.00 | $0.00 | $0.00 | $0.00 |
| Share repurchases | — | — | — | — | — |
| Debt repayment | — | — | — | — | — |
| Net change in cash | — | — | — | — | — |